Pro-Dex (PDEX) Competitors $45.05 +1.46 (+3.35%) Closing price 04:00 PM EasternExtended Trading$45.10 +0.05 (+0.11%) As of 07:17 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock PDEX vs. BFLY, KIDS, DCTH, AXGN, SMLR, TMCI, NPCE, OM, CLPT, and CATXShould you be buying Pro-Dex stock or one of its competitors? The main competitors of Pro-Dex include Butterfly Network (BFLY), OrthoPediatrics (KIDS), Delcath Systems (DCTH), AxoGen (AXGN), Semler Scientific (SMLR), Treace Medical Concepts (TMCI), NeuroPace (NPCE), Outset Medical (OM), ClearPoint Neuro (CLPT), and Perspective Therapeutics (CATX). These companies are all part of the "medical equipment" industry. Pro-Dex vs. Its Competitors Butterfly Network OrthoPediatrics Delcath Systems AxoGen Semler Scientific Treace Medical Concepts NeuroPace Outset Medical ClearPoint Neuro Perspective Therapeutics Butterfly Network (NYSE:BFLY) and Pro-Dex (NASDAQ:PDEX) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their media sentiment, earnings, analyst recommendations, dividends, risk, institutional ownership, profitability and valuation. Do institutionals and insiders believe in BFLY or PDEX? 37.9% of Butterfly Network shares are owned by institutional investors. Comparatively, 15.3% of Pro-Dex shares are owned by institutional investors. 25.2% of Butterfly Network shares are owned by company insiders. Comparatively, 47.5% of Pro-Dex shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Does the media prefer BFLY or PDEX? In the previous week, Butterfly Network had 3 more articles in the media than Pro-Dex. MarketBeat recorded 4 mentions for Butterfly Network and 1 mentions for Pro-Dex. Pro-Dex's average media sentiment score of 0.97 beat Butterfly Network's score of 0.25 indicating that Pro-Dex is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Butterfly Network 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Pro-Dex 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger valuation & earnings, BFLY or PDEX? Pro-Dex has lower revenue, but higher earnings than Butterfly Network. Butterfly Network is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioButterfly Network$82.06M5.94-$72.49M-$0.29-6.79Pro-Dex$53.84M2.73$2.13M$2.8016.09 Do analysts recommend BFLY or PDEX? Butterfly Network currently has a consensus price target of $3.50, indicating a potential upside of 77.66%. Pro-Dex has a consensus price target of $56.00, indicating a potential upside of 24.31%. Given Butterfly Network's higher probable upside, equities research analysts clearly believe Butterfly Network is more favorable than Pro-Dex.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Butterfly Network 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Pro-Dex 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is BFLY or PDEX more profitable? Pro-Dex has a net margin of 14.61% compared to Butterfly Network's net margin of -75.56%. Pro-Dex's return on equity of 29.08% beat Butterfly Network's return on equity.Company Net Margins Return on Equity Return on Assets Butterfly Network-75.56% -29.97% -21.13% Pro-Dex 14.61%29.08%16.19% Which has more volatility & risk, BFLY or PDEX? Butterfly Network has a beta of 2.46, meaning that its stock price is 146% more volatile than the S&P 500. Comparatively, Pro-Dex has a beta of 0.19, meaning that its stock price is 81% less volatile than the S&P 500. SummaryPro-Dex beats Butterfly Network on 8 of the 15 factors compared between the two stocks. Get Pro-Dex News Delivered to You Automatically Sign up to receive the latest news and ratings for PDEX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PDEX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PDEX vs. The Competition Export to ExcelMetricPro-DexMED/DENTAL IndustryMedical SectorNASDAQ ExchangeMarket Cap$142.15M$15.74B$5.54B$8.87BDividend YieldN/A1.41%5.39%4.10%P/E Ratio16.0918.6926.1719.90Price / Sales2.732.33414.67113.66Price / Cash45.5216.9736.1356.90Price / Book4.993.858.055.38Net Income$2.13M$430.42M$3.15B$248.50M7 Day Performance6.85%3.24%1.85%2.97%1 Month Performance14.81%3.08%4.81%6.02%1 Year Performance151.25%20.67%34.86%20.39% Pro-Dex Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PDEXPro-Dex2.2259 of 5 stars$45.05+3.3%$56.00+24.3%+137.5%$142.15M$53.84M16.09140News CoverageBFLYButterfly Network2.2104 of 5 stars$2.05-1.4%$4.00+95.1%+118.5%$514.36M$82.06M-7.07460News CoverageAnalyst ForecastKIDSOrthoPediatrics4.2374 of 5 stars$20.59+1.5%$35.83+74.0%-22.5%$492.77M$204.73M-11.77200DCTHDelcath Systems3.6145 of 5 stars$13.26-4.3%$24.00+81.0%+54.5%$482.34M$37.21M-26.5260Gap DownAXGNAxoGen2.6976 of 5 stars$9.79+0.6%$22.20+126.8%+42.2%$443.14M$187.34M-65.26450Positive NewsSMLRSemler Scientific2.3008 of 5 stars$41.99+16.2%$71.00+69.1%+5.0%$403.02M$56.29M-16.09120Gap UpHigh Trading VolumeTMCITreace Medical Concepts2.5924 of 5 stars$5.74+4.2%$10.16+77.0%-7.2%$346.52M$209.36M-6.75250NPCENeuroPace3.2631 of 5 stars$10.57+1.5%$15.50+46.6%+43.2%$341.43M$79.91M-12.58170High Trading VolumeOMOutset Medical1.6856 of 5 stars$17.37-8.5%$27.00+55.4%-62.5%$336.37M$113.69M-0.60520News CoverageHigh Trading VolumeCLPTClearPoint Neuro2.2883 of 5 stars$11.36+0.9%$25.00+120.1%+111.3%$315.16M$31.39M-14.95110Positive NewsCATXPerspective Therapeutics1.6588 of 5 stars$4.11+18.8%$12.56+205.5%-70.7%$305.08M$1.43M0.0070 Related Companies and Tools Related Companies BFLY Competitors KIDS Competitors DCTH Competitors AXGN Competitors SMLR Competitors TMCI Competitors NPCE Competitors OM Competitors CLPT Competitors CATX Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PDEX) was last updated on 7/2/2025 by MarketBeat.com Staff From Our PartnersTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredTrump's ticking time bombA looming tariff deadline on July 9th could be the spark — but what’s buried inside a recent White House docum...Porter & Company | Sponsored“E.I.”- The biggest prediction of my career?One expert predicts that E.I. could see over 200,000% growth... But you need to move fast...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pro-Dex, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pro-Dex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
